Symbol:
Wnt2
Name:
Wnt family member 2
RGD ID:
621346
Description:
Predicted to enable cytokine activity and frizzled binding activity. Involved in lung development and positive regulation of endothelial cell proliferation. Predicted to be located in collagen-containing extracellular matrix; cytoplasm; and extracellular region. Human ortholog(s) of this gene implicated in breast carcinoma; hepatocellular carcinoma; and urinary system cancer. Orthologous to human WNT2 (Wnt family member 2); PARTICIPATES IN Wnt signaling pathway; Wnt signaling, canonical pathway; basal cell carcinoma pathway; INTERACTS WITH 1,3-dinitrobenzene; 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
protein Wnt-2; wingless-related MMTV integration site 2; wingless-type MMTV integration site 2; wingless-type MMTV integration site family member 2; Wnt
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 4 47,294,300 - 47,340,284 (-) NCBI GRCr8 mRatBN7.2 4 46,328,408 - 46,374,673 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 4 46,333,998 - 46,374,402 (-) Ensembl mRatBN7.2 Ensembl Rnor_6.0 4 45,286,845 - 45,332,899 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 4 45,292,437 - 45,332,420 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 4 45,892,395 - 45,936,605 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 4 43,649,783 - 43,689,596 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 4 43,857,074 - 43,859,488 (-) NCBI Celera 4 41,596,263 - 41,642,309 (-) NCBI Celera Cytogenetic Map 4 q22 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Wnt2 Rat (1->4)-beta-D-glucan multiple interactions ISO Wnt2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of WNT2 mRNA CTD PMID:36331819 Wnt2 Rat 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of WNT2 mRNA CTD PMID:21983209 Wnt2 Rat 1-nitropyrene increases expression ISO WNT2 (Homo sapiens) 6480464 1-nitropyrene results in increased expression of WNT2 mRNA CTD PMID:21540303 Wnt2 Rat 17beta-estradiol increases expression ISO WNT2 (Homo sapiens) 6480464 Estradiol results in increased expression of WNT2 mRNA CTD PMID:15072547 Wnt2 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of WNT2 mRNA CTD PMID:32145629 Wnt2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Wnt2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of WNT2 mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to WNT2 promoter] CTD PMID:16214954 and PMID:19654925 Wnt2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO WNT2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of WNT2 mRNA CTD PMID:36370075 Wnt2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Wnt2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of WNT2 mRNA CTD PMID:26377647 and PMID:36222588 Wnt2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Wnt2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of WNT2 mRNA CTD PMID:18172886 and PMID:25975270 Wnt2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of WNT2 mRNA CTD PMID:23238561 Wnt2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Wnt2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of WNT2 mRNA CTD PMID:23238561 Wnt2 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Wnt2 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 Wnt2 Rat 4,4'-diaminodiphenylmethane decreases expression ISO Wnt2 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of WNT2 mRNA CTD PMID:18648102 Wnt2 Rat 4,4'-sulfonyldiphenol increases expression ISO Wnt2 (Mus musculus) 6480464 bisphenol S results in increased expression of WNT2 mRNA CTD PMID:30951980 Wnt2 Rat 4,4'-sulfonyldiphenol decreases methylation ISO Wnt2 (Mus musculus) 6480464 bisphenol S results in decreased methylation of WNT2 exon CTD PMID:33297965 Wnt2 Rat 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of WNT2 mRNA CTD PMID:21346803 Wnt2 Rat 5-aza-2'-deoxycytidine multiple interactions ISO WNT2 (Homo sapiens) 6480464 Decitabine inhibits the reaction [bisphenol A results in increased methylation of WNT2 promoter] CTD PMID:30303745 Wnt2 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of WNT2 mRNA CTD PMID:24780913 and PMID:30047161 Wnt2 Rat afimoxifene increases expression ISO WNT2 (Homo sapiens) 6480464 afimoxifene results in increased expression of WNT2 mRNA CTD PMID:15072547 Wnt2 Rat all-trans-retinoic acid decreases expression ISO WNT2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of WNT2 mRNA CTD PMID:17045167 Wnt2 Rat amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of WNT2 mRNA CTD PMID:30047161 Wnt2 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of WNT2 mRNA CTD PMID:16483693 Wnt2 Rat antirheumatic drug increases expression ISO WNT2 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of WNT2 mRNA CTD PMID:24449571 Wnt2 Rat arsenite(3-) increases expression ISO Wnt2 (Mus musculus) 6480464 arsenite results in increased expression of WNT2 mRNA CTD PMID:33053406 Wnt2 Rat arsenite(3-) increases methylation ISO WNT2 (Homo sapiens) 6480464 arsenite results in increased methylation of WNT2 promoter CTD PMID:23974009 Wnt2 Rat Azoxymethane multiple interactions ISO Wnt2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of WNT2 mRNA CTD PMID:29950665 Wnt2 Rat benzo[a]pyrene multiple interactions ISO Wnt2 (Mus musculus) 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to WNT2 promoter] CTD PMID:19654925 Wnt2 Rat benzo[a]pyrene affects methylation ISO WNT2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of WNT2 promoter CTD PMID:27901495 Wnt2 Rat benzo[a]pyrene increases expression ISO Wnt2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of WNT2 mRNA CTD PMID:22228805 and PMID:32417428 Wnt2 Rat benzo[a]pyrene increases mutagenesis ISO WNT2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased mutagenesis of WNT2 gene CTD PMID:25435355 Wnt2 Rat bisphenol A increases expression ISO Wnt2 (Mus musculus) 6480464 bisphenol A results in increased expression of WNT2 mRNA CTD PMID:24465770 more ... Wnt2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of WNT2 mRNA CTD PMID:32145629 Wnt2 Rat bisphenol A increases methylation ISO WNT2 (Homo sapiens) 6480464 bisphenol A results in increased methylation of WNT2 promoter CTD PMID:30303745 Wnt2 Rat bisphenol A decreases expression ISO WNT2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of WNT2 protein CTD PMID:30303745 Wnt2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of WNT2 mRNA CTD PMID:30816183 and PMID:31129395 Wnt2 Rat bisphenol A multiple interactions ISO WNT2 (Homo sapiens) 6480464 Decitabine inhibits the reaction [bisphenol A results in increased methylation of WNT2 promoter] CTD PMID:30303745 Wnt2 Rat bisphenol A decreases expression ISO Wnt2 (Mus musculus) 6480464 bisphenol A results in decreased expression of WNT2 mRNA and bisphenol A results in decreased expression of WNT2 protein CTD PMID:30303745 Wnt2 Rat bisphenol A increases methylation ISO Wnt2 (Mus musculus) 6480464 bisphenol A results in increased methylation of WNT2 promoter CTD PMID:30303745 Wnt2 Rat bisphenol F increases expression ISO Wnt2 (Mus musculus) 6480464 bisphenol F results in increased expression of WNT2 mRNA CTD PMID:30951980 Wnt2 Rat cadmium dichloride multiple interactions ISO WNT2 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA CTD PMID:12634122 Wnt2 Rat carbon nanotube decreases expression ISO Wnt2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Wnt2 Rat chloroprene decreases expression ISO Wnt2 (Mus musculus) 6480464 Chloroprene results in decreased expression of WNT2 mRNA CTD PMID:23125180 Wnt2 Rat chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of WNT2 mRNA CTD PMID:23125180 Wnt2 Rat chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of WNT2 mRNA CTD PMID:18502319 Wnt2 Rat clotrimazole decreases expression EXP 6480464 Clotrimazole results in decreased expression of WNT2 mRNA CTD PMID:30047161 Wnt2 Rat cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of WNT2 mRNA CTD PMID:27899881 Wnt2 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of WNT2 mRNA CTD PMID:26577399 Wnt2 Rat deguelin increases expression ISO WNT2 (Homo sapiens) 6480464 deguelin results in increased expression of WNT2 mRNA CTD PMID:19861542 Wnt2 Rat dextran sulfate multiple interactions ISO Wnt2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of WNT2 mRNA CTD PMID:29950665 Wnt2 Rat diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of WNT2 mRNA CTD PMID:18502319 Wnt2 Rat dichromium trioxide multiple interactions ISO WNT2 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA CTD PMID:12634122 Wnt2 Rat dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of WNT2 mRNA CTD PMID:19130878 Wnt2 Rat dioxygen multiple interactions ISO WNT2 (Homo sapiens) 6480464 CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of WNT2 mRNA] CTD PMID:26305601 Wnt2 Rat dioxygen multiple interactions ISO Wnt2 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WNT2 mRNA CTD PMID:30529165 Wnt2 Rat dioxygen increases expression ISO WNT2 (Homo sapiens) 6480464 [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of WNT2 mRNA CTD PMID:26305601 Wnt2 Rat dorsomorphin multiple interactions ISO WNT2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT2 mRNA CTD PMID:27188386 Wnt2 Rat doxorubicin decreases expression ISO WNT2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of WNT2 mRNA CTD PMID:29803840 Wnt2 Rat entinostat increases expression ISO WNT2 (Homo sapiens) 6480464 entinostat results in increased expression of WNT2 mRNA CTD PMID:27188386 Wnt2 Rat ethanol increases expression ISO WNT2 (Homo sapiens) 6480464 Ethanol results in increased expression of WNT2 mRNA CTD PMID:31059573 Wnt2 Rat ethylparaben increases expression ISO WNT2 (Homo sapiens) 6480464 ethyl-p-hydroxybenzoate results in increased expression of WNT2 mRNA CTD PMID:37690743 Wnt2 Rat finasteride affects expression EXP 6480464 Finasteride affects the expression of WNT2 mRNA CTD PMID:30768126 Wnt2 Rat fulvestrant decreases expression ISO WNT2 (Homo sapiens) 6480464 fulvestrant results in decreased expression of WNT2 mRNA CTD PMID:15072547 Wnt2 Rat glufosinate decreases expression ISO Wnt2 (Mus musculus) 6480464 phosphinothricin results in decreased expression of WNT2 mRNA CTD PMID:34597628 Wnt2 Rat lead diacetate multiple interactions ISO WNT2 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA CTD PMID:12634122 Wnt2 Rat lipopolysaccharide multiple interactions ISO WNT2 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Wnt2 Rat methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of WNT2 mRNA CTD PMID:30047161 Wnt2 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of WNT2 gene CTD PMID:35440735 Wnt2 Rat N(gamma)-nitro-L-arginine methyl ester multiple interactions ISO Wnt2 (Mus musculus) 6480464 ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of WNT2 protein] CTD PMID:34995009 Wnt2 Rat N(gamma)-nitro-L-arginine methyl ester decreases expression ISO Wnt2 (Mus musculus) 6480464 NG-Nitroarginine Methyl Ester results in decreased expression of WNT2 protein CTD PMID:34995009 Wnt2 Rat N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of WNT2 mRNA CTD PMID:28801915 Wnt2 Rat N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO WNT2 (Homo sapiens) 6480464 Methylnitronitrosoguanidine results in increased expression of WNT2 mRNA CTD PMID:12634122 Wnt2 Rat N-nitrosodiethylamine decreases expression ISO Wnt2 (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of WNT2 mRNA CTD PMID:24535843 Wnt2 Rat nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of WNT2 mRNA CTD PMID:19130878 Wnt2 Rat nickel subsulfide decreases expression EXP 6480464 nickel subsulfide results in decreased expression of WNT2 mRNA CTD PMID:24952340 Wnt2 Rat nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of WNT2 mRNA CTD PMID:17270562 and PMID:18280291 Wnt2 Rat nitrofen decreases expression ISO Wnt2 (Mus musculus) 6480464 nitrofen results in decreased expression of WNT2 mRNA CTD PMID:21034933 Wnt2 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of WNT2 mRNA and [Topotecan co-treated with oxaliplatin] results in decreased expression of WNT2 mRNA CTD PMID:25729387 Wnt2 Rat oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of WNT2 mRNA CTD PMID:25729387 Wnt2 Rat ozone multiple interactions ISO Wnt2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of WNT2 mRNA CTD PMID:34911549 Wnt2 Rat paracetamol affects expression ISO Wnt2 (Mus musculus) 6480464 Acetaminophen affects the expression of WNT2 mRNA CTD PMID:17562736 Wnt2 Rat paraquat increases expression EXP 6480464 Paraquat results in increased expression of WNT2 mRNA CTD PMID:32680482 Wnt2 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Wnt2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of WNT2 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of WNT2 mRNA CTD PMID:36331819 Wnt2 Rat phenobarbital affects expression ISO Wnt2 (Mus musculus) 6480464 Phenobarbital affects the expression of WNT2 mRNA CTD PMID:23091169 Wnt2 Rat resveratrol decreases expression ISO WNT2 (Homo sapiens) 6480464 resveratrol results in decreased expression of WNT2 mRNA and resveratrol results in decreased expression of WNT2 protein CTD PMID:25061499 and PMID:25896424 Wnt2 Rat S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO WNT2 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in increased expression of WNT2 mRNA CTD PMID:35811015 Wnt2 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO WNT2 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 Wnt2 Rat SB 431542 multiple interactions ISO WNT2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT2 mRNA CTD PMID:27188386 Wnt2 Rat silicon dioxide increases expression ISO WNT2 (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of WNT2 mRNA CTD PMID:21540303 Wnt2 Rat sodium arsenite multiple interactions ISO WNT2 (Homo sapiens) 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA CTD PMID:12634122 Wnt2 Rat sodium arsenite increases expression ISO WNT2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of WNT2 mRNA CTD PMID:38568856 Wnt2 Rat titanium dioxide multiple interactions ISO Wnt2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of WNT2 mRNA CTD PMID:29950665 Wnt2 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of WNT2 mRNA CTD PMID:25729387 Wnt2 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of WNT2 mRNA and [Topotecan co-treated with oxaliplatin] results in decreased expression of WNT2 mRNA CTD PMID:25729387 Wnt2 Rat triclosan decreases expression ISO WNT2 (Homo sapiens) 6480464 Triclosan results in decreased expression of WNT2 mRNA CTD PMID:30510588 Wnt2 Rat triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of WNT2 mRNA CTD PMID:30589522 Wnt2 Rat valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of WNT2 promoter CTD PMID:20734317 Wnt2 Rat valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of WNT2 mRNA and Valproic Acid results in increased expression of WNT2 protein CTD PMID:20734317 Wnt2 Rat valproic acid decreases methylation ISO WNT2 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of WNT2 gene CTD PMID:29154799 Wnt2 Rat valproic acid increases expression ISO WNT2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of WNT2 mRNA CTD PMID:23179753 more ... Wnt2 Rat valproic acid multiple interactions ISO WNT2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT2 mRNA CTD PMID:27188386
Imported Annotations - KEGG (archival)
(1->4)-beta-D-glucan (ISO) 1,3-dinitrobenzene (EXP) 1-nitropyrene (ISO) 17beta-estradiol (EXP,ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 4,4'-diaminodiphenylmethane (ISO) 4,4'-sulfonyldiphenol (ISO) 4-amino-2,6-dinitrotoluene (EXP) 5-aza-2'-deoxycytidine (ISO) 6-propyl-2-thiouracil (EXP) afimoxifene (ISO) all-trans-retinoic acid (ISO) amitrole (EXP) ammonium chloride (EXP) antirheumatic drug (ISO) arsenite(3-) (ISO) Azoxymethane (ISO) benzo[a]pyrene (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) cadmium dichloride (ISO) carbon nanotube (ISO) chloroprene (EXP,ISO) chlorpyrifos (EXP) clotrimazole (EXP) cocaine (EXP) Cuprizon (EXP) deguelin (ISO) dextran sulfate (ISO) diazinon (EXP) dichromium trioxide (ISO) dieldrin (EXP) dioxygen (ISO) dorsomorphin (ISO) doxorubicin (ISO) entinostat (ISO) ethanol (ISO) ethylparaben (ISO) finasteride (EXP) fulvestrant (ISO) glufosinate (ISO) lead diacetate (ISO) lipopolysaccharide (ISO) methimazole (EXP) methoxychlor (EXP) N(gamma)-nitro-L-arginine methyl ester (ISO) N-methyl-4-phenylpyridinium (EXP) N-methyl-N'-nitro-N-nitrosoguanidine (ISO) N-nitrosodiethylamine (ISO) nickel atom (EXP) nickel subsulfide (EXP) nitrofen (EXP,ISO) oxaliplatin (EXP) ozone (ISO) paracetamol (ISO) paraquat (EXP) perfluorooctane-1-sulfonic acid (ISO) phenobarbital (ISO) resveratrol (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) SB 431542 (ISO) silicon dioxide (ISO) sodium arsenite (ISO) titanium dioxide (ISO) topotecan (EXP) triclosan (ISO) triphenyl phosphate (EXP) valproic acid (EXP,ISO)
1.
Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma.
Bui TD, etal., Br J Cancer. 1997;75(8):1131-6.
2.
Differential expression of Wnt genes in normal and flat variants of PC12 cells, a cell line responsive to ectopic Wnt1 expression.
Erdreich-Epstein A and Shackleford GM, Growth Factors 1998;15(2):149-58.
3.
Long-term feeding of various fat diets modulates azoxymethane-induced colon carcinogenesis through Wnt/beta-catenin signaling in rats.
Fujise T, etal., Am J Physiol Gastrointest Liver Physiol. 2007 Apr;292(4):G1150-6. Epub 2006 Dec 28.
4.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
5.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
6.
Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.
Habuchi T, etal., J Natl Cancer Inst. 1994 Sep 7;86(17):1331-5.
7.
Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue.
Huguet EL, etal., Cancer Res. 1994 May 15;54(10):2615-21.
8.
Frizzled-9 is activated by Wnt-2 and functions in Wnt/beta -catenin signaling.
Karasawa T, etal., J Biol Chem 2002 Oct 4;277(40):37479-86.
9.
Wnt2 acts as a cell type-specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway.
Klein D, etal., Hepatology. 2008 Mar;47(3):1018-31.
10.
Growth and developmental regulation of wnt-2 (irp) gene in mesenchymal cells of fetal lung.
Levay-Young BK and Navre M, Am J Physiol. 1992 Jun;262(6 Pt 1):L672-83.
11.
Influence of polymorphisms in the Wnt/β-catenin pathway genes on hepatocellular carcinoma risk in a Chinese Han population.
Li QM, etal., Medicine (Baltimore). 2017 Mar;96(12):e6127. doi: 10.1097/MD.0000000000006127.
12.
Chronic electroconvulsive seizure up-regulates beta-catenin expression in rat hippocampus: role in adult neurogenesis.
Madsen TM, etal., Biol Psychiatry. 2003 Nov 15;54(10):1006-14.
13.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
14.
Analysis of genetic alterations related to the development and progression of breast carcinoma.
Nagayama K and Watatani M, Jpn J Cancer Res. 1993 Nov;84(11):1159-64.
15.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
16.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
17.
GOA pipeline
RGD automated data pipeline
18.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
19.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
20.
Comprehensive gene review and curation
RGD comprehensive gene curation
21.
Wnt signaling in the ovary: identification and compartmentalized expression of wnt-2, wnt-2b, and frizzled-4 mRNAs.
Ricken A, etal., Endocrinology 2002 Jul;143(7):2741-9.
22.
The Wnt Homepage
Roel Nusse - Howard Hughes Medical Institute and the Department of Developmental Biology at Stanford University, California, USA
23.
Transformation by Wnt family proteins correlates with regulation of beta-catenin.
Shimizu H, etal., Cell Growth Differ. 1997 Dec;8(12):1349-58.
24.
Alternative wnt signaling is initiated by distinct receptors.
van Amerongen R, etal., Sci Signal. 2008 Sep 2;1(35):re9.
25.
Independent amplification of two gene clusters on chromosome 4 in rat endometrial cancer: identification and molecular characterization.
Walentinsson A, etal., Cancer Res 2001 Nov 15;61(22):8263-73.
26.
A dual-color FISH gene map of the proximal region of rat Chromosome 4 and comparative analysis in human and mouse.
Walentinsson A, etal., Mamm Genome 2001 Dec;12(12):900-8.
27.
Expression of twist and wnt in human breast cancer.
Watanabe O, etal., Anticancer Res. 2004 Nov-Dec;24(6):3851-6.
28.
WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.
Wissmann C, etal., J Pathol 2003 Oct;201(2):204-12.
29.
Differential transformation of mammary epithelial cells by Wnt genes.
Wong GT, etal., Mol Cell Biol. 1994 Sep;14(9):6278-86.
Wnt2 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 4 47,294,300 - 47,340,284 (-) NCBI GRCr8 mRatBN7.2 4 46,328,408 - 46,374,673 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 4 46,333,998 - 46,374,402 (-) Ensembl mRatBN7.2 Ensembl Rnor_6.0 4 45,286,845 - 45,332,899 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 4 45,292,437 - 45,332,420 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 4 45,892,395 - 45,936,605 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 4 43,649,783 - 43,689,596 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 4 43,857,074 - 43,859,488 (-) NCBI Celera 4 41,596,263 - 41,642,309 (-) NCBI Celera Cytogenetic Map 4 q22 NCBI
WNT2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 7 117,275,451 - 117,323,058 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 7 117,275,451 - 117,323,152 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 7 116,915,505 - 116,963,112 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 7 116,704,518 - 116,750,579 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 7 116,511,232 - 116,557,294 NCBI Celera 7 111,724,862 - 111,771,525 (-) NCBI Celera Cytogenetic Map 7 q31.2 NCBI HuRef 7 111,282,485 - 111,328,966 (-) NCBI HuRef CHM1_1 7 116,850,055 - 116,896,705 (-) NCBI CHM1_1 T2T-CHM13v2.0 7 118,590,786 - 118,638,396 (-) NCBI T2T-CHM13v2.0 CRA_TCAGchr7v2 7 116,312,120 - 116,358,781 (-) NCBI
Wnt2 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 6 17,988,939 - 18,032,771 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 6 17,988,939 - 18,030,584 (-) Ensembl GRCm39 Ensembl GRCm38 6 17,985,474 - 18,032,772 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 6 17,988,940 - 18,030,585 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 6 17,938,940 - 17,980,445 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 6 17,938,940 - 17,980,356 (-) NCBI MGSCv36 mm8 Celera 6 18,070,129 - 18,111,436 (-) NCBI Celera Cytogenetic Map 6 A2 NCBI cM Map 6 8.08 NCBI
Wnt2 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955432 22,984,170 - 23,027,705 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955432 22,988,208 - 23,024,530 (-) NCBI ChiLan1.0 ChiLan1.0
WNT2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 6 154,101,025 - 154,151,405 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 7 6,111,284 - 6,161,665 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 7 109,244,772 - 109,291,472 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 7 121,939,254 - 121,985,862 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 7 121,936,031 - 121,985,862 (-) Ensembl panpan1.1 panPan2
WNT2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 14 56,123,735 - 56,172,113 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 14 56,129,248 - 56,172,069 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 14 55,519,061 - 55,567,484 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 14 56,163,101 - 56,211,441 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 14 56,166,256 - 56,213,190 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 14 56,195,055 - 56,243,473 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 14 55,884,128 - 55,931,047 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 14 56,253,933 - 56,302,214 (-) NCBI UU_Cfam_GSD_1.0
Wnt2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405118 44,819,573 - 44,865,128 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936589 1,825,209 - 1,866,889 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936589 1,825,209 - 1,866,898 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
WNT2 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 18 28,946,326 - 28,993,961 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 18 28,945,825 - 28,993,969 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 18 30,790,071 - 30,838,269 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
WNT2 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 21 85,955,517 - 86,005,664 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 21 85,955,145 - 86,001,730 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666042 17,730,443 - 17,777,632 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Wnt2 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 111 Count of miRNA genes: 92 Interacting mature miRNAs: 99 Transcripts: ENSRNOT00000010427 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
2302371 Stl22 Serum triglyceride level QTL 22 5.15 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 4 5218294 57114705 Rat 2303585 Bw86 Body weight QTL 86 4 body mass (VT:0001259) body weight (CMO:0000012) 4 14678065 59678065 Rat 1358352 Srcrt3 Stress Responsive Cort QTL 3 2.29 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 4 38465774 146803430 Rat 61445 Strs3 Sensitivity to stroke QTL 3 3 cerebrum integrity trait (VT:0010549) post-insult time to onset of cerebrovascular lesion (CMO:0002343) 4 40433388 85433388 Rat 6893678 Bw108 Body weight QTL 108 2.6 0.006 body mass (VT:0001259) body weight (CMO:0000012) 4 43457976 88457976 Rat 8552906 Pigfal3 Plasma insulin-like growth factor 1 level QTL 3 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 4 10084089 55084089 Rat 10755501 Bp390 Blood pressure QTL 390 2.5 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 4 26775591 168368347 Rat 1331807 Rf31 Renal function QTL 31 2.988 urine potassium amount (VT:0010539) urine potassium level (CMO:0000128) 4 39524264 74726312 Rat 6478766 Anxrr47 Anxiety related response QTL 47 0.09637 locomotor behavior trait (VT:0001392) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 4 10084089 55084089 Rat 8552782 Vie1 Viral induced encephalitis QTL 1 26.4 brain integrity trait (VT:0010579) encephalitis incidence/prevalence measurement (CMO:0002361) 4 34430484 82490359 Rat 631642 Stl2 Serum triglyceride level QTL 2 3.3 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 4 5219178 56647776 Rat 6478769 Anxrr48 Anxiety related response QTL 48 0.02514 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 4 10084089 55084089 Rat 631261 Tcas3 Tongue tumor susceptibility QTL 3 6.88 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 4 10814170 91360527 Rat 2312567 Glom19 Glomerulus QTL 19 1.9 0.006 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 4 45456990 146803430 Rat 2313401 Anxrr27 Anxiety related response QTL 27 aggression-related behavior trait (VT:0015014) tameness/aggressiveness composite score (CMO:0002136) 4 17933508 62933508 Rat 8655961 Kidm43 Kidney mass QTL 43 18 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 4 36303261 103194984 Rat 1354612 Foco1 Food consumption QTL 1 8.87 eating behavior trait (VT:0001431) food intake rate (CMO:0000427) 4 44463908 148090542 Rat 6909128 Pancm4 Pancreatic morphology QTL 4 11.35 pancreas mass (VT:0010144) pancreas wet weight (CMO:0000626) 4 26907285 75585128 Rat 8694374 Bw155 Body weight QTL 155 3.39 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 4 10084089 55084089 Rat 2303168 Bp330 Blood pressure QTL 330 4.25 0.017 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 4 5214602 146446691 Rat 8552801 Bw143 Body weight QTL 143 7.3 body mass (VT:0001259) change in body weight to body weight ratio (CMO:0002216) 4 34430484 82490359 Rat 61475 Aia2 Adjuvant induced arthritis QTL 2 5.8 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 4 39505275 73892441 Rat 8694439 Bw168 Body weight QTL 168 9.57 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 4 40433414 85433414 Rat 61412 Pia2 Pristane induced arthritis QTL 2 3.9 joint integrity trait (VT:0010548) post-insult time to onset of experimental arthritis (CMO:0001450) 4 21333343 62278020 Rat 6478724 Anxrr35 Anxiety related response QTL 35 0.00449 defecation behavior trait (VT:0010462) defecation measurement (CMO:0000997) 4 10084089 55084089 Rat 8655906 Rf60 Renal function QTL 60 3.8 blood creatinine amount (VT:0005328) creatinine clearance (CMO:0000765) 4 29494195 81006281 Rat 619616 Bp79 Blood pressure QTL 79 0.0292 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 4 5214602 78882945 Rat 1576305 Emca6 Estrogen-induced mammary cancer QTL 6 5.8 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 4 44463720 155883716 Rat 7387227 Uae40 Urinary albumin excretion QTL 40 2.9 0.0052 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 4 17946999 62946999 Rat 6909122 Insul22 Insulin level QTL 22 4.63 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 4 26907285 75585128 Rat 8552809 Vie5 Viral induced encephalitis QTL 5 25.3 brain integrity trait (VT:0010579) encephalitis incidence/prevalence measurement (CMO:0002361) 4 34430484 82490359 Rat 1358203 Stl19 Serum triglyceride level QTL 19 2.8 0.002 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 4 5218294 65958103 Rat 1354660 Salc1 Saline consumption QTL 1 11.26 drinking behavior trait (VT:0001422) saline drink intake rate (CMO:0001627) 4 44463908 148090542 Rat 9590304 Scort17 Serum corticosterone level QTL 17 4.96 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 4 10084089 55084089 Rat 1300139 Hrtrt6 Heart rate QTL 6 2.85 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 4 39524264 116179656 Rat 12798520 Anxrr55 Anxiety related response QTL 55 4.45 0.01 locomotor behavior trait (VT:0001392) number of rearing movements with lid-pushing in an experimental apparatus (CMO:0002715) 4 32583980 114627242 Rat 11530004 Niddm71 Non-insulin dependent diabetes mellitus QTL 71 0.001 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 4 32584199 52754138 Rat 2316958 Gluco58 Glucose level QTL 58 10 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 4 11320076 180699135 Rat
RH141342
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 4 46,365,759 - 46,365,947 (+) MAPPER mRatBN7.2 Rnor_6.0 4 45,323,804 - 45,323,991 NCBI Rnor6.0 Rnor_5.0 4 45,927,743 - 45,927,930 UniSTS Rnor5.0 RGSC_v3.4 4 43,680,955 - 43,681,142 UniSTS RGSC3.4 Celera 4 41,633,214 - 41,633,401 UniSTS RH 3.4 Map 4 281.51 UniSTS Cytogenetic Map 4 q21-q22 UniSTS
RH130031
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 4 46,334,021 - 46,334,214 (+) MAPPER mRatBN7.2 Rnor_6.0 4 45,292,068 - 45,292,260 NCBI Rnor6.0 Rnor_5.0 4 45,896,007 - 45,896,199 UniSTS Rnor5.0 RGSC_v3.4 4 43,649,219 - 43,649,411 UniSTS RGSC3.4 Celera 4 41,601,486 - 41,601,678 UniSTS RH 3.4 Map 4 284.1 UniSTS Cytogenetic Map 4 q21-q22 UniSTS
REN63976
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 4 46,368,043 - 46,368,267 (+) MAPPER mRatBN7.2 Rnor_6.0 4 45,326,088 - 45,326,311 NCBI Rnor6.0 Rnor_5.0 4 45,930,027 - 45,930,250 UniSTS Rnor5.0 RGSC_v3.4 4 43,683,239 - 43,683,462 UniSTS RGSC3.4 Celera 4 41,635,498 - 41,635,721 UniSTS Cytogenetic Map 4 q21-q22 UniSTS
Wnt2
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 4 46,366,948 - 46,367,198 (+) MAPPER mRatBN7.2 Rnor_6.0 4 45,324,993 - 45,325,242 NCBI Rnor6.0 Rnor_5.0 4 45,928,932 - 45,929,181 UniSTS Rnor5.0 RGSC_v3.4 4 43,682,144 - 43,682,393 UniSTS RGSC3.4 Celera 4 41,634,403 - 41,634,652 UniSTS Cytogenetic Map 4 q21-q22 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
8
11
48
113
91
90
59
25
59
6
216
96
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000083039 ⟹ ENSRNOP00000071025
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 4 46,333,998 - 46,374,402 (-) Ensembl Rnor_6.0 Ensembl 4 45,292,437 - 45,332,420 (-) Ensembl
RefSeq Acc Id:
NM_053695 ⟹ NP_446147
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 4 47,294,300 - 47,340,284 (-) NCBI
Ensembl Acc Id:
ENSRNOP00000071025 ⟸ ENSRNOT00000083039
RefSeq Acc Id:
NP_446147 ⟸ NM_053695
- Peptide Label:
precursor
- UniProtKB:
A0A0G2JZF4 (UniProtKB/TrEMBL), A6IE38 (UniProtKB/TrEMBL), Q2IBD1 (UniProtKB/TrEMBL)
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2017-03-29
Wnt2
Wnt family member 2
Wnt2
wingless-type MMTV integration site family member 2
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-11-14
Wnt2
wingless-type MMTV integration site family member 2
Wnt2
wingless-related MMTV integration site 2
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2003-04-09
Wnt2
wingless-related MMTV integration site 2
Symbol and Name updated
629477
APPROVED
2003-03-12
Wnt2
wingless-related MMTV integration site 2
Wnt
Data merged from RGD:619763
628472
PROVISIONAL
2002-08-07
Wnt2
Symbol and Name status set to provisional
70820
PROVISIONAL
2002-08-07
Wnt
Symbol and Name status set to provisional
70820
PROVISIONAL
Note Type
Note
Reference
gene_expression
expressed in uterus
70557
gene_process
upregulated in uterine tumors
70557